Society guideline links: Side effects of anti-inflammatory and anti-rheumatic drugs

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Canada

●Canadian Rheumatology Association (CRA): Chronic pain, diclofenac, and cardiovascular risk – Management algorithm (2014)

●CRA: Diclofenac position statement (2014)

United States

●American College of Rheumatology (ACR): Guideline for the management of reproductive health in rheumatic and musculoskeletal diseases (2020)

●ACR: Guideline for the prevention and treatment of glucocorticoid-induced osteoporosis (2017)

●Choosing Wisely: Don't perform methotrexate toxicity labs more often than every 12 weeks on stable doses (2013)

●Choosing Wisely: Avoid nonsteroidal anti-inflammatory drugs (NSAIDS) in individuals with hypertension or heart failure or CKD of all causes, including diabetes (2012)

Europe

●European League Against Rheumatism (EULAR): Points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation (2015)

United Kingdom

●British Society for Rheumatology (BSR): Biologic DMARD safety guidelines in inflammatory arthritis (2018)

●Choosing Wisely UK: British Society of Rheumatology – Bisphosphonate therapy should be reviewed with every patient after 3-5 years, and a treatment holiday considered. This should follow a shared-decision making conversation which includes the risks and benefits of continued treatment (2018)

●BSR and British Health Professionals in Rheumatology (BHPR): Guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs (2017)

●BSR and BHPR: Guideline on prescribing drugs in pregnancy and breastfeeding – Analgesics and other drugs used in rheumatology practice (2016)

●BSR and BHPR: Guideline on prescribing drugs in pregnancy and breastfeeding – Standard and biologic disease modifying anti-rheumatic drugs and corticosteroids (2016)

Australia-New Zealand

●Australian Rheumatology Association (ARA): Rheumatology fertility preservation guidelines (2018, updated 2022)